期刊文献+

呼吸内科下呼吸道感染病原菌分布及耐药性分析 被引量:5

Distribution and drug resistance of pathogens contributing to lower respiratory tract infections in the department of respiratory medicine
原文传递
导出
摘要 目的探讨和分析下呼吸道感染患者的病原菌分布及其耐药性。方法回顾性分析2013年在金华市中心医院呼吸内科住院的下呼吸道感染患者合格痰标本细菌培养结果,然后进行细菌菌株的鉴定和药物敏感性检测。结果共分离出593株致病菌。其中,革兰阴性菌464株,占78.2%,前四位为:肺炎克雷伯菌、铜绿假单胞菌、鲍曼不动杆菌、大肠埃希菌;革兰阳性菌49株(占8.3%),以金黄色葡萄球菌为主;真菌80株(占13.5%),以白假丝酵母菌为主。不论是革兰阴性杆菌还是革兰阳性球菌均普遍出现了多重耐药菌株。结论呼吸内科下呼吸道感染以革兰阴性菌为主,分离病原菌耐药现象普遍存在,临床应重视病原学检查。加强病原菌耐药性监测,合理使用抗菌药物。 Objective To investigate the distribution and drug resistance of pathogens causing lower respiratory tract infections. Methods A retrospective study was conducted to analyze the culture results and drug susceptibility of the bacterial strains from qualified sputum samples from hospitalized patients with lower respiratory tract infections in 2013 in the department of respiratory medicine in our hospital. Results In total 593 pathogens isolated,464 strains were gram-negative bacilli(78. 2%),49 were gram-positive bacilli(8. 3%),and 80 were fungi(13.5%). Among gram-negative bacilli,the top four isolates were Klebsiella pneumoniae,Pseudomonas aeruginosa,Acinetobacter baumannii and Escherichia coli. The most common gram-positive bacteria and fungi were Staphylococcus aureus and Candida albicans,respectively. Either Gram-negative or Gram-positive strains showed multidrug resistance. Conclusion Gram-negative bacilli are the most common pathogens causing lower respiratory tract infections. Multi-drug resistance is very common among the isolates in this study. Clinical physicians should pay more attention to the etiological examination,drug resistance monitoring and rational use of antimicrobial drugs.
出处 《中国微生态学杂志》 CAS CSCD 2014年第8期900-902,913,共4页 Chinese Journal of Microecology
基金 教育部博士点博导基金(2012010111008) 卫生部国家临床重点专科建设项目
关键词 下呼吸道感染 病原菌 耐药性 Lower respiratory tract infections Pathogen Drug resistance
  • 相关文献

参考文献7

  • 1社区获得性肺炎诊断和治疗指南[J].中华结核和呼吸杂志,2006,29(10):651-655. 被引量:3057
  • 2章小芳,叶丽娟.院内感染新生儿肺炎病原菌分布特点及干预对策[J].中国微生态学杂志,2014,26(2):188-191. 被引量:18
  • 3Zhang X, Wang R, Di X, et al. Different microbiological and clin- ical aspects of lower respiratory tract infections between China and European/American countries [ J]. J Thorac Dis, 2014, 6 ( 2 ) : 134-142.
  • 4Aliberti S, Cilloniz C, Chalmers JD, et al. Multidrug-resistant pathogens in bospitalised patients coming from the community with pneumonia: a European perspective[ J]. Thorax, 2013, 68 ( 11 ) : 997-999.
  • 5Pitout JD, Laupland KB. Extended-spectrum β-lactamase-producing Enterobacteriaceae : an emerging public-health concern [ J ]. Lancet, 2008, 8(3): 159-166.
  • 6Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 21 th informational supplement [ S ]. Document MIO0-S21 s. Wayne, PA, USA : CLSI. 2011.
  • 7吴春明,宋建新,曹家麟,朱小区,欧阳钦.主动外排泵在铜绿假单胞菌多药耐药机制中的作用实验研究[J].中华医院感染学杂志,2011,21(9):1721-1723. 被引量:12

二级参考文献32

  • 1沈定霞,罗燕萍,崔岩,赵莉萍,白立彦.分离产金属β-内酰胺酶的铜绿假单胞菌[J].中华医院感染学杂志,2004,14(1):86-88. 被引量:109
  • 2刘又宁,陈民钧,赵铁梅,王辉,王睿,刘庆锋,蔡柏蔷,曹彬,孙铁英,胡云建,修清玉,周新,丁星,杨岚,卓建生,唐英春,张扣兴,梁德荣,吕晓菊,李胜歧,刘勇,俞云松,魏泽庆,应可净,赵峰,陈萍,侯晓娜.中国城市成人社区获得性肺炎665例病原学多中心调查[J].中华结核和呼吸杂志,2006,29(1):3-8. 被引量:788
  • 3Daigle DM, Cao L, Fraud S, etal. Protein modulator of multidrug efflux gene expression in Pseudomonas aeruginosa [J]. J Bacteriol, 2007,189(15) : 5441-5451.
  • 4Robertson GT, Doyle TB, Du Q, etal. A Novel indole compound that inhibits Pseudornonas aeruginosa growth by targeting MreB is a substrate for MexAB-OprM[J]. J Bacteriol 2007,189(19) :6870-6881.
  • 5Dumas JL, Van Delden C, Perron K, etal. Analysis of antibiotic resistance genes expression in Pseudomonas aeruginosa by quantitative real time PCR[J]. FEMS Microbiol Lett, 2006,254(2) :217-225.
  • 6Wu CM, Cao JL, Song JX, et al. Effect and mechanism of andrographolide on the recovery of Pseudomonas aeruginosa susceptibility to several antibiotics[J]. Int Med Res,2008,36 (1) :178-186.
  • 7Ngeow YF,Suwanjutha S,Chantarojanasriri T,et al.An Asian study on the prevalence of atypical respiratory pathogens in community-acquired pneumonia.Int J Infect Dis,2005,9:144-153.
  • 8de Roux A,Marcos MA,Garcia E,et al.Viral community-acquired pneumonia in nonimmunocompromised adults.Chest,2004,125:1343-1351.
  • 9Ostrosky-Zeichner L,Alexander BD,Kett DH,et al.Multicenter clinical evaluation of the (1→3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans.Clin Infect Dis,2005,41:654-659.
  • 10Food and Drug Administration,HHS.Class Ⅱ Special Controls Guidance Document:serological assays for the detection of betaglucan.Fed Reqist,2004,69:56934-56936.

共引文献3082

同被引文献53

引证文献5

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部